May 3, 2026 · Form 4 insider transaction
Lin Shao-Lee bought 655,074 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
This stock option becomes exercisable in 48 equal monthly installments beginning on April 30, 2026.